MATTERS II - Mistral Percutaneous Tricuspid Valve Repair FIM Study

Status Completed

Clinical Trial Summary

The Mistral is an investigational device intended for percutaneous trans-catheter repair in high risk for surgery individuals suffering from functional Tricuspid Regurgitation (TR). The device system is to be used only in accordance with the approved Investigational Plan on subjects who have signed an informed consent form. Device use is limited to the approved study investigators.

Clinical Trial Description

The study is designed to clinically demonstrate device acute safety and technical performance (Primary Endpoints) along with longer FU device safety and effectiveness evaluation (Secondary Endpoint). The main objectives of the study are: - Evaluate the Acute safety of the implanted Mistral device post procedure and at 30 day follow up period. - Evaluate the long term Safety of the device. - Demonstrate effectiveness of the Mistral device in reducing TR. Primary endpoints: - Safety: Acute safety. Rate of all SAEs including device related SAEs, all caused mortality, stroke, MI, cardiac tamponade, surgery for failed percutaneous repair and non-elective cardiovascular surgery to treat an adverse event. At discharge and 30 days. - Performance: Mistral Implantation rate of technical success (defined as successful device implantation with grasped chords from at least two leaflets.). Secondary endpoints: - Safety: Safety at 3,6, 12 and 24 months. Rate of all SAEs including device related SAEs at 3, 6, 12 and 24 months. - Effectiveness: TR reduction post-procedure, at discharge and 30 days, 3,6, 12 and 24 months. Improved NYHA class, 6MWTdistance and KCCQ (quality of life) at 30 days, 3,6, 12 and 24 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04073979
Study type	Interventional
Source	Mitralix
Contact
Status	Completed
Phase	N/A
Start date	April 2, 2019
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01246947` - Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation	N/A
Recruiting	`NCT04577248` - The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Completed	`NCT02787408` - The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System	N/A
Completed	`NCT02981953` - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System	N/A
Active, not recruiting	`NCT04221490` - 2019-06 TRISCEND Study	N/A
Completed	`NCT01585779` - Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial	N/A
Recruiting	`NCT05194423` - THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein	N/A
Recruiting	`NCT05767645` - Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study	N/A
Completed	`NCT01246141` - The Comparison of Tricuspid Replacement and Repair in Patients With Combined Heart Valve Disease	N/A
Withdrawn	`NCT03928639` - Structural Heart and Valve Network PROSPECTIVE Registry
Not yet recruiting	`NCT05577078` - TriBEL Registry: National Belgian Registry of Percutaneous Tricuspid Valve Repair Using a Transcatheter Edge-to-edge Repair Technique
Recruiting	`NCT05760989` - TRISCEND JAPAN Study	N/A
Completed	`NCT02471807` - Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System	N/A
Completed	`NCT04071652` - MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study	N/A
Active, not recruiting	`NCT04483089` - An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated With the Abbott TriClip™ Device (bRIGHT)
Not yet recruiting	`NCT05936125` - Short Term Outcomes Of Tricuspid Valve Annuloplasty Using A Flexible Band	N/A
Recruiting	`NCT04482062` - TRISCEND II Pivotal Trial	N/A